Ali Hama Amin1, Fahad Alqahtani2, Sami Aljohani2, Peter Farjo2, Kinjan Patel2, Akram Kawasra2, Annina Guzek2, Mohamad Alkhouli3. 1. Division of Cardiovascular Disease, West Virginia University, Morgantown, WV, United States of America; Section of Cardiology, Carilion Clinic, Virginia Tech-Carilion School of Medicine, Roanoke, VA, United States of America. Electronic address: ali.hamaamin@gmail.com. 2. Division of Cardiovascular Disease, West Virginia University, Morgantown, WV, United States of America. 3. Division of Cardiovascular Disease, West Virginia University, Morgantown, WV, United States of America; Department of Cardiology, Mayo Clinic School of Medicine, Rochester, MN, United States of America.
Abstract
BACKGROUND: The safety of same day discharge (SDD) after percutaneous coronary interventions (PCI) has been demonstrated in several studies. However, SDD was only allowed in patients meeting strict criteria. We aimed to evaluate the feasibility and safety of SDD following elective-PCI in all comers. METHODS: In 2012, we implemented a strategy of SDD for all elective PCI (no exclusion) but admissions were allowed at the discretion of the treating physician. We assessed the feasibility and safety of this approach in consecutive patients who underwent elective PCI at WVU. RESULTS: Out of 3355 patients who underwent PCI between 2012 and 2016, 691 (21%) presented electively. Radial access was utilized in 480 (69.5%). Same day discharge was achieved in 539/691 (78%), and there was no difference between patients who had SDD and those who were admitted with regards to the 30-day major adverse cardiovascular and cerebrovascular events (3.2% vs. 3.5% respectively, P = 0.195). Predictors of SDD failure were procedural complications (OR 12.08, 95%CI 2.20-57.8. P = 0.002), use of Glycoprotein IIB-IIIA inhibitors (OR 3.45, 95%CI 1.067-11.41, P = 0.039), femoral access (OR 2.067, 95%CI 1.25-3.419, p = 0.005), anemia (OR 1.80, 95%CI 1.06-3.04, P = 0.029), home distance ≥60 miles (OR 1.68, 95%CI 1.03-2.72, P = 0.037). CONCLUSION: SDD is feasible in the majority of all-comers after elective PCI, and is not associated with increase in adverse events at 30-days. Certain procedural and patient's characteristics predict SDD failure. If validated in prospective studies, these factors can possibly be integrated in a predictive tool to aid in triaging patients, post-elective PCI.
BACKGROUND: The safety of same day discharge (SDD) after percutaneous coronary interventions (PCI) has been demonstrated in several studies. However, SDD was only allowed in patients meeting strict criteria. We aimed to evaluate the feasibility and safety of SDD following elective-PCI in all comers. METHODS: In 2012, we implemented a strategy of SDD for all elective PCI (no exclusion) but admissions were allowed at the discretion of the treating physician. We assessed the feasibility and safety of this approach in consecutive patients who underwent elective PCI at WVU. RESULTS: Out of 3355 patients who underwent PCI between 2012 and 2016, 691 (21%) presented electively. Radial access was utilized in 480 (69.5%). Same day discharge was achieved in 539/691 (78%), and there was no difference between patients who had SDD and those who were admitted with regards to the 30-day major adverse cardiovascular and cerebrovascular events (3.2% vs. 3.5% respectively, P = 0.195). Predictors of SDD failure were procedural complications (OR 12.08, 95%CI 2.20-57.8. P = 0.002), use of Glycoprotein IIB-IIIA inhibitors (OR 3.45, 95%CI 1.067-11.41, P = 0.039), femoral access (OR 2.067, 95%CI 1.25-3.419, p = 0.005), anemia (OR 1.80, 95%CI 1.06-3.04, P = 0.029), home distance ≥60 miles (OR 1.68, 95%CI 1.03-2.72, P = 0.037). CONCLUSION: SDD is feasible in the majority of all-comers after elective PCI, and is not associated with increase in adverse events at 30-days. Certain procedural and patient's characteristics predict SDD failure. If validated in prospective studies, these factors can possibly be integrated in a predictive tool to aid in triaging patients, post-elective PCI.
Authors: Adhir Shroff; Joel Kupfer; Ian C Gilchrist; Ronald Caputo; Bernadette Speiser; Olivier F Bertrand; Samir B Pancholy; Sunil V Rao Journal: JAMA Cardiol Date: 2016-05-01 Impact factor: 14.676
Authors: Rishi K Wadhera; Devraj Sukul; Eric A Secemsky; Changyu Shen; Hitinder S Gurm; William E Boden; Robert W Yeh Journal: JAMA Intern Med Date: 2019-02-01 Impact factor: 21.873
Authors: Eltigani Abdelaal; Sunil V Rao; Ian C Gilchrist; Ivo Bernat; Adhir Shroff; Ronald Caputo; Olivier Costerousse; Samir B Pancholy; Olivier F Bertrand Journal: JACC Cardiovasc Interv Date: 2013-01-23 Impact factor: 11.195
Authors: Amit P Amin; Duane Pinto; John A House; Sunil V Rao; John A Spertus; Mauricio G Cohen; Samir Pancholy; Adam C Salisbury; Mamas A Mamas; Nathan Frogge; Jasvindar Singh; John Lasala; Frederick A Masoudi; Steven M Bradley; Jason H Wasfy; Thomas M Maddox; Hemant Kulkarni Journal: JAMA Cardiol Date: 2018-11-01 Impact factor: 14.676
Authors: G Dorros; M J Cowley; J Simpson; L G Bentivoglio; P C Block; M Bourassa; K Detre; A J Gosselin; A R Grüntzig; S F Kelsey; K M Kent; M B Mock; S M Mullin; R K Myler; E R Passamani; S H Stertzer; D O Williams Journal: Circulation Date: 1983-04 Impact factor: 29.690
Authors: Purushothaman Muthusamy; Denise K Busman; Alan T Davis; David H Wohns Journal: Catheter Cardiovasc Interv Date: 2012-09-20 Impact factor: 2.692
Authors: Gerlind S Heyde; Karel T Koch; Robbert J de Winter; Marcel G W Dijkgraaf; Margriet I Klees; Lea M Dijksman; Jan J Piek; Jan G P Tijssen Journal: Circulation Date: 2007-04-09 Impact factor: 29.690
Authors: Kais Hyasat; Giuseppe Femia; Karam Alzuhairi; Andrew Ha; Joseph Kamand; Edmund Hasche; Rohan Rajaratnam; Sidney Lo; Hamid Almafragy; Kevin Liou; Joseph Chiha; Kaleab Asrress Journal: Clin Med Insights Cardiol Date: 2022-08-23